 Mary Coussons-Read
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aggression | 6 | 2016 | 200 | 1.780 |
Why?
| | Interleukin-6 | 13 | 2023 | 786 | 1.510 |
Why?
| | Hydrocortisone | 7 | 2024 | 313 | 1.380 |
Why?
| | Pregnancy Complications | 7 | 2024 | 535 | 1.290 |
Why?
| | Postpartum Period | 9 | 2024 | 344 | 1.220 |
Why?
| | Depression, Postpartum | 5 | 2024 | 135 | 1.200 |
Why?
| | C-Reactive Protein | 7 | 2016 | 411 | 1.170 |
Why?
| | Anxiety | 7 | 2024 | 1066 | 1.110 |
Why?
| | Personality Disorders | 4 | 2019 | 72 | 1.000 |
Why?
| | Pregnancy | 26 | 2024 | 6830 | 0.960 |
Why?
| | Inflammation | 7 | 2021 | 2856 | 0.840 |
Why?
| | Sleep | 4 | 2024 | 796 | 0.830 |
Why?
| | Affect | 1 | 2024 | 311 | 0.740 |
Why?
| | Depression | 8 | 2024 | 1465 | 0.720 |
Why?
| | Stress, Psychological | 6 | 2022 | 1124 | 0.670 |
Why?
| | Cytokines | 7 | 2023 | 2084 | 0.660 |
Why?
| | Morphine | 6 | 2001 | 167 | 0.650 |
Why?
| | Kynurenine | 2 | 2019 | 114 | 0.610 |
Why?
| | Sleep Initiation and Maintenance Disorders | 2 | 2021 | 193 | 0.610 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2023 | 1248 | 0.580 |
Why?
| | Premature Birth | 3 | 2023 | 340 | 0.570 |
Why?
| | Corticotropin-Releasing Hormone | 3 | 2024 | 75 | 0.570 |
Why?
| | Biomarkers | 6 | 2021 | 4111 | 0.560 |
Why?
| | Pregnancy Trimesters | 2 | 2006 | 18 | 0.510 |
Why?
| | Receptors, Interleukin-1 Type II | 1 | 2015 | 6 | 0.460 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 2 | 2016 | 12 | 0.460 |
Why?
| | Tryptophan | 1 | 2016 | 183 | 0.450 |
Why?
| | Circadian Rhythm | 4 | 2024 | 490 | 0.430 |
Why?
| | Pituitary-Adrenal System | 6 | 2024 | 171 | 0.430 |
Why?
| | Hypothalamo-Hypophyseal System | 6 | 2024 | 206 | 0.420 |
Why?
| | Health Status Indicators | 1 | 2013 | 165 | 0.390 |
Why?
| | Inflammation Mediators | 2 | 2013 | 513 | 0.390 |
Why?
| | Female | 37 | 2024 | 73891 | 0.380 |
Why?
| | Adult | 25 | 2024 | 38291 | 0.370 |
Why?
| | Adjuvants, Immunologic | 2 | 2008 | 237 | 0.370 |
Why?
| | Sleep Deprivation | 2 | 2021 | 181 | 0.370 |
Why?
| | Gestational Age | 4 | 2021 | 916 | 0.360 |
Why?
| | Pregnancy Trimester, Third | 4 | 2023 | 115 | 0.350 |
Why?
| | Adaptation, Psychological | 2 | 2013 | 672 | 0.340 |
Why?
| | Interleukin-10 | 4 | 2023 | 304 | 0.330 |
Why?
| | Saliva | 4 | 2024 | 239 | 0.330 |
Why?
| | Social Support | 3 | 2016 | 628 | 0.320 |
Why?
| | Lymphocytes | 3 | 2008 | 399 | 0.310 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2018 | 560 | 0.310 |
Why?
| | Young Adult | 13 | 2024 | 13321 | 0.310 |
Why?
| | Self Report | 1 | 2013 | 839 | 0.300 |
Why?
| | Anxiety Disorders | 5 | 2023 | 375 | 0.300 |
Why?
| | Animal Husbandry | 1 | 2009 | 37 | 0.290 |
Why?
| | Agricultural Workers' Diseases | 1 | 2009 | 31 | 0.290 |
Why?
| | Xylans | 1 | 2008 | 4 | 0.280 |
Why?
| | Shiitake Mushrooms | 1 | 2008 | 2 | 0.280 |
Why?
| | Health Behavior | 1 | 2013 | 776 | 0.280 |
Why?
| | Rats, Inbred Lew | 8 | 2008 | 113 | 0.280 |
Why?
| | Oryza | 1 | 2008 | 32 | 0.280 |
Why?
| | Orthomyxoviridae Infections | 2 | 1999 | 68 | 0.270 |
Why?
| | Lymphocyte Activation | 6 | 2008 | 1145 | 0.270 |
Why?
| | Humans | 38 | 2024 | 138631 | 0.270 |
Why?
| | Epigenesis, Genetic | 3 | 2021 | 647 | 0.270 |
Why?
| | Sleep Wake Disorders | 2 | 2008 | 301 | 0.260 |
Why?
| | Immunity, Cellular | 2 | 2001 | 270 | 0.250 |
Why?
| | Pregnancy Trimester, First | 2 | 2022 | 137 | 0.250 |
Why?
| | Seasons | 1 | 2009 | 538 | 0.240 |
Why?
| | Aging | 3 | 2021 | 1857 | 0.240 |
Why?
| | Plant Extracts | 1 | 2008 | 209 | 0.240 |
Why?
| | Impulsive Behavior | 3 | 2016 | 151 | 0.230 |
Why?
| | Neuroimmunomodulation | 2 | 1995 | 66 | 0.230 |
Why?
| | Spinal Puncture | 2 | 2015 | 19 | 0.230 |
Why?
| | Leukocytes, Mononuclear | 1 | 2007 | 570 | 0.220 |
Why?
| | Narcolepsy | 1 | 2004 | 22 | 0.220 |
Why?
| | Interferon-gamma | 3 | 2021 | 789 | 0.220 |
Why?
| | Conditioning, Classical | 2 | 1995 | 107 | 0.210 |
Why?
| | Human Growth Hormone | 1 | 2004 | 48 | 0.210 |
Why?
| | Acculturation | 2 | 2016 | 54 | 0.210 |
Why?
| | Wakefulness | 1 | 2024 | 136 | 0.200 |
Why?
| | Killer Cells, Natural | 4 | 2008 | 455 | 0.200 |
Why?
| | Mexican Americans | 2 | 2016 | 114 | 0.200 |
Why?
| | Catecholamines | 1 | 2002 | 91 | 0.190 |
Why?
| | Interleukin-2 | 3 | 2008 | 451 | 0.190 |
Why?
| | Longitudinal Studies | 5 | 2023 | 2838 | 0.180 |
Why?
| | Placenta | 3 | 2024 | 752 | 0.180 |
Why?
| | Personality Inventory | 2 | 2014 | 141 | 0.180 |
Why?
| | Chorioamnionitis | 1 | 2021 | 42 | 0.180 |
Why?
| | Mothers | 3 | 2022 | 764 | 0.170 |
Why?
| | Male | 21 | 2020 | 68214 | 0.170 |
Why?
| | Picolinic Acids | 2 | 2019 | 9 | 0.170 |
Why?
| | Pregnancy Outcome | 3 | 2021 | 425 | 0.160 |
Why?
| | Maternal Behavior | 1 | 2020 | 79 | 0.160 |
Why?
| | Interleukins | 1 | 2021 | 251 | 0.160 |
Why?
| | Receptors, Cannabinoid | 1 | 2019 | 15 | 0.160 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2022 | 611 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 2 | 2023 | 474 | 0.160 |
Why?
| | Birth Weight | 2 | 2020 | 511 | 0.150 |
Why?
| | Rats | 8 | 2008 | 5593 | 0.150 |
Why?
| | Endocannabinoids | 1 | 2019 | 64 | 0.150 |
Why?
| | Infant | 5 | 2023 | 9565 | 0.140 |
Why?
| | Altitude | 1 | 2002 | 467 | 0.140 |
Why?
| | Personality | 1 | 2019 | 130 | 0.140 |
Why?
| | Influenza A virus | 1 | 1999 | 110 | 0.140 |
Why?
| | Psychometrics | 2 | 2014 | 726 | 0.140 |
Why?
| | Prenatal Care | 1 | 2020 | 298 | 0.140 |
Why?
| | Orthomyxoviridae | 1 | 1998 | 40 | 0.140 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 321 | 0.130 |
Why?
| | Middle Aged | 9 | 2021 | 33788 | 0.130 |
Why?
| | Quinolinic Acid | 1 | 2016 | 8 | 0.130 |
Why?
| | Kynurenic Acid | 1 | 2016 | 20 | 0.130 |
Why?
| | Mental Health | 1 | 2022 | 735 | 0.120 |
Why?
| | Toxoplasmosis | 1 | 2016 | 41 | 0.120 |
Why?
| | Maze Learning | 1 | 1996 | 103 | 0.120 |
Why?
| | Child Development | 1 | 2020 | 471 | 0.120 |
Why?
| | Exploratory Behavior | 1 | 1996 | 91 | 0.120 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2015 | 29 | 0.120 |
Why?
| | Pregnancy Trimester, Second | 2 | 2022 | 81 | 0.110 |
Why?
| | Receptors, Adrenergic, beta | 2 | 1994 | 69 | 0.110 |
Why?
| | Depressive Disorder | 1 | 2018 | 390 | 0.110 |
Why?
| | Nadolol | 1 | 1994 | 4 | 0.110 |
Why?
| | Receptors, Opioid | 1 | 1994 | 27 | 0.110 |
Why?
| | Reference Values | 2 | 2008 | 804 | 0.110 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2015 | 237 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 1999 | 374 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2014 | 299 | 0.100 |
Why?
| | Pilot Projects | 2 | 2020 | 1757 | 0.100 |
Why?
| | Lung | 3 | 2001 | 4086 | 0.100 |
Why?
| | Antibody Formation | 1 | 1994 | 299 | 0.100 |
Why?
| | Models, Genetic | 1 | 1996 | 590 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2001 | 1076 | 0.100 |
Why?
| | Mitogens | 2 | 2008 | 59 | 0.100 |
Why?
| | Serotonin | 1 | 2015 | 322 | 0.100 |
Why?
| | Nitric Oxide | 2 | 1994 | 894 | 0.090 |
Why?
| | Dopamine | 1 | 2015 | 308 | 0.090 |
Why?
| | Motor Activity | 1 | 1996 | 715 | 0.090 |
Why?
| | Macrophages | 3 | 1998 | 1544 | 0.080 |
Why?
| | Case-Control Studies | 2 | 2016 | 3580 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 1994 | 867 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2039 | 0.080 |
Why?
| | Suicidal Ideation | 1 | 2015 | 532 | 0.080 |
Why?
| | Down Syndrome | 1 | 1996 | 486 | 0.080 |
Why?
| | Oxidative Stress | 1 | 2015 | 1326 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2007 | 888 | 0.070 |
Why?
| | Suicide | 1 | 2016 | 659 | 0.070 |
Why?
| | Avena | 1 | 2008 | 4 | 0.070 |
Why?
| | Animals | 10 | 2008 | 37302 | 0.070 |
Why?
| | Superantigens | 1 | 2008 | 70 | 0.070 |
Why?
| | Adolescent | 5 | 2016 | 21528 | 0.070 |
Why?
| | Enterotoxins | 1 | 2008 | 88 | 0.070 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2001 | 225 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 2008 | 104 | 0.070 |
Why?
| | Seeds | 1 | 2008 | 86 | 0.070 |
Why?
| | Spleen | 2 | 2008 | 523 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2007 | 4174 | 0.070 |
Why?
| | Life Change Events | 2 | 2021 | 152 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 1996 | 4333 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 851 | 0.050 |
Why?
| | Sleep Stages | 1 | 2004 | 50 | 0.050 |
Why?
| | Serum | 1 | 2004 | 60 | 0.050 |
Why?
| | Infant, Newborn | 3 | 2023 | 6143 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2016 | 5519 | 0.050 |
Why?
| | Dietary Supplements | 1 | 2008 | 562 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2024 | 149 | 0.050 |
Why?
| | Mood Disorders | 1 | 2023 | 135 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 71 | 0.050 |
Why?
| | Chronic Disease | 1 | 2009 | 1800 | 0.050 |
Why?
| | Psychopathology | 1 | 2022 | 57 | 0.050 |
Why?
| | Fetal Death | 1 | 2021 | 57 | 0.050 |
Why?
| | Self Efficacy | 1 | 2005 | 400 | 0.050 |
Why?
| | Optimism | 1 | 2021 | 6 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2004 | 1320 | 0.040 |
Why?
| | Vitamins | 1 | 2022 | 188 | 0.040 |
Why?
| | Nitrites | 1 | 2001 | 88 | 0.040 |
Why?
| | Age Factors | 1 | 2009 | 3273 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2001 | 162 | 0.040 |
Why?
| | Nitrates | 1 | 2001 | 94 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2473 | 0.040 |
Why?
| | Epigenomics | 1 | 2020 | 115 | 0.040 |
Why?
| | Glycerides | 1 | 2019 | 22 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2019 | 64 | 0.040 |
Why?
| | Estradiol | 1 | 2002 | 525 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1999 | 127 | 0.040 |
Why?
| | Colorado | 1 | 2009 | 4528 | 0.040 |
Why?
| | Sex Factors | 1 | 2004 | 2058 | 0.040 |
Why?
| | Drug Implants | 1 | 1998 | 83 | 0.030 |
Why?
| | omega-N-Methylarginine | 2 | 1994 | 31 | 0.030 |
Why?
| | Concanavalin A | 2 | 1994 | 75 | 0.030 |
Why?
| | Mice, Neurologic Mutants | 1 | 1996 | 21 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 648 | 0.030 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 1996 | 36 | 0.030 |
Why?
| | Anger | 1 | 2016 | 63 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2015 | 25 | 0.030 |
Why?
| | Arginine | 2 | 1994 | 260 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 1996 | 269 | 0.030 |
Why?
| | Mexico | 1 | 2016 | 233 | 0.030 |
Why?
| | Risk Factors | 3 | 2016 | 10395 | 0.030 |
Why?
| | Trisomy | 1 | 1996 | 75 | 0.030 |
Why?
| | Arousal | 1 | 1996 | 156 | 0.030 |
Why?
| | Avoidance Learning | 1 | 1995 | 74 | 0.030 |
Why?
| | DNA Methylation | 1 | 2020 | 637 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 5867 | 0.030 |
Why?
| | Social Environment | 1 | 1996 | 293 | 0.030 |
Why?
| | Electroshock | 1 | 1994 | 143 | 0.030 |
Why?
| | Transcriptome | 1 | 2020 | 970 | 0.030 |
Why?
| | Naltrexone | 1 | 1994 | 100 | 0.030 |
Why?
| | Proteins | 1 | 1999 | 1014 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2015 | 279 | 0.020 |
Why?
| | Parenting | 1 | 2015 | 315 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2016 | 903 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2384 | 0.020 |
Why?
| | Family | 1 | 2016 | 677 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1310 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 2012 | 142 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1015 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5729 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7639 | 0.020 |
Why?
| | Mental Disorders | 1 | 2016 | 1091 | 0.020 |
Why?
| | United States | 2 | 2016 | 15017 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 856 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 5091 | 0.020 |
Why?
| | Child | 1 | 2024 | 21883 | 0.010 |
Why?
| | Mice | 1 | 1996 | 17841 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1994 | 1093 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1994 | 366 | 0.010 |
Why?
|
|
Coussons-Read's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|